The Strüngmann Group, led by Andreas and Thomas Strüngmann, is a prominent investment firm focusing on biotech, pharma, life sciences, and healthcare sectors. The group is known for its significant investments in companies like BioNTech, which played a crucial role in developing a COVID-19 vaccine in partnership with Pfizer.
Focus Areas
Notable Investments
